Bedside monitoring of blood β-hydroxybutyrate levels in the management of diabetic ketoacidosis in children

Diabetes Technology and Therapeutics

Volumn 8, Issue 6, 2006, Pages 671-676

  Rewers, Arleta ^a   Mcfann, Kin ^a   Chase, H Peter ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; BICARBONATE; CARBON DIOXIDE; ELECTROLYTE; GLUCOSE; INSULIN; NITROGEN; UREA;

ADOLESCENT; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD GAS; BLOOD PH; CARBON DIOXIDE TENSION; CORRELATION ANALYSIS; DEVICE; DIABETIC KETOACIDOSIS; ELECTROLYTE BLOOD LEVEL; EMERGENCY WARD; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POINT OF CARE TESTING; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD; UREA NITROGEN BLOOD LEVEL; VENOUS BLOOD;

3-HYDROXYBUTYRIC ACID; ADOLESCENT; CHILD; DIABETIC KETOACIDOSIS; ELECTROCHEMISTRY; FEMALE; HUMANS; MALE; POINT-OF-CARE SYSTEMS;

EID: 33845321085     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.671     Document Type: Article

References (20)

1. Levy-Marchal C, Papoz L, de Beaufort C, Doutreix J, Froment V, Voirin J, Czernichow P: Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabet Med 1992;9:279-284.
2. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, Hamman RF, Klingensmith G: Predictors of acute complications in children with type 1 diabetes. JAMA 2002;287:2511-2518.
3. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society: European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 2004;113:e133-e140.
4. Maldonado MR, Chong ER, Oehl MA, Balasubramanyam A: Economic impact of diabetic ketoacidosis in a multiethnic indigent population: analysis of costs based on the precipitating cause. Diabetes Care 2003;26:1265-1269.
5. Edge JA, Ford-Adams ME, Dunger DB: Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child 1999;81:318-323.
6. Laffel L: Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999;15:412-426.
7. Schade DS, Eaton RP: Metabolic and clinical significance of ketosis. Spec Top Endocrinol Metab 1982;4:1-27.
8. Byrne HA, Tieszen KL, Hollis S, Dornan TL, New JP: Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care 2000;23:500-503.
9. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
10. Ham MR, Okada P, White PC: Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting. Pediatr Diabetes 2004;5:39-43.
11. Kreshak A, Chen EH: Arterial blood gas analysis: are its values needed for the management of diabetic ketoacidosis? Ann Emerg Med 2005;45:550-551.
12. Ma OJ, Rush MD, Godfrey MM, Gaddis G: Arterial blood gas results rarely influence emergency physician management of patients with suspected diabetic ketoacidosis. Acad Emerg Med 2003;10:836-841.
13. Khan AS, Talbot JA, Tieszen KL, Gardener EA, Gibson JM, New JP: Evaluation of a bedside blood ketone sensor: the effects of acidosis, hyperglycaemia and acetoacetate on sensor performance. Diabet Med 2004;21:782-785.
14. Taboulet P, Haas L, Porcher R, Manamani J, Fontaine JP, Feugeas JP, Gautier JF: Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the Emergency Department setting. Eur J Emerg Med 2004;11:251-258.
15. Bektas F, Eray O, Sari R, Akbas H: Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res 2004;30:395-402.
16. Wallace TM, Meston NM, Gardner SG, Matthews DR: The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabet Med 2001;18:640-645.
17. Harris S, Ng R, Syed H, Hillson R. Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis. Diabet Med 2005;22:221-224.
18. Nadgir UM, Silver FL, MacGillivray MH: Unrecognized persistence of beta-hydroxybutyrate in diabetic ketoacidosis. Endocr Res 2001;27:41-16.
19. Vanelli M, Chiari G, Capuano C, lovane B, Bernardini A, Giacalone T: The direct measurement of 3-beta-hydroxy butyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment. Diabetes Nutr Metab 2003;16:312-316.
20. Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S: Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med 2006;23:278-284.